PIPELINE

Pipeline

Pipeline table
Pipeline Target Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3
MFC0101 Glioblastoma
35%
Solid Tumor
35%
Brain Metastases
30%
Viral Disease
30%
MFC0102 NASH
14.5%
MFC0201 Glioblastoma
14.5%
MFC0202 Leukemia
9.5%
MFC0301 Glioblastoma
9.5%
MFB0102 Solid tumor / Blood cancer
14.5%
MFB0202 Solid tumor / Blood cancer
14.5%